Overview of the top rankic
This page provides practical, Australia-focused information about chloroquine: common uses, standard drug dose patterns, safety concerns to address, rough retail prices in the AUD currency, and lawful ways to obtain it australia-based. Use the navigation above to jump to dosing, negative potential side effects or access that meets legal standards.
A concise view of the main details:
- Common strengths: chloroquine phosphate tablets typically come as 250 mg or 500 mg strengths. A 500 mg phosphate tablet corresponds to about 300 mg of chloroquine base.
- Main clinical roles: historically an antimalarial and used for certain tissue-invasive amoebic infections. It is not recommended for viral illnesses such as COVID-19.
- Formulation note: products are usually labelled as the phosphate salt; dosing is often converted to chloroquine base for clarity.
- Branding and supply: international brand names include Aralen; in Australia most supplies will be generic and availability varies between pharmacies and travel clinics.
Want brief comparisons or cost and pricing model outlook estimates? See Further Options and Australian dollar price evaluation. For advice on supervision and monitoring, jump to Keeping under surveillance and Safety.
Portents and Primary applications
When used appropriately, chloroquine has specific roles in clinical practice. Typical signs include:
- Treatment and suppression of malaria caused by Plasmodium vivax, P. ovale and P. malariae, and for strains of P. falciparum that remain sensitive to chloroquine.
- Adjunctive therapy for extraintestinal amebiasis as part of combination regimens for tissue-invasive disease. For the radical cure of P. between Plasmodium vivax and P. ovale an 8-aminoquinoline such as primaquine or tafenoquine is usually added when safe to do so.
Note that chloroquine resistance in P. falciparum is widespread in many parts of the world; travel medicine clinics can advise on the best prophylactic or treatment option for your destination.
Using This Guide Chloroquine Safely
Follow the instructions your prescriber gave you exactly. The practical tips below help reduce collateral effects and improve adherence.
- Take tablets with food or a glass of milk if you get stomach upset, unless your clinician instructs otherwise.
- For weekly prophylaxis schedules, take the dose on the same day each week to make it easier to remember.
- If the regimen is twice daily, common timings are with breakfast alongside the evening meal.
- Complete the full course prescribed even if symptoms improve before the medicine is finished.
- If you forget to take your dose, take it when you remember unless the next dose is due soon; do not take two doses together to make up for a skipped dose.
For child dosing and specific regimens see Dose Regimen and Timetable. Check conditions under which this therapy should be avoided at Reasons to avoid use and Safety procedures to Follow and any potential Drug Interaction Terminology before you begin the process.
Medication Dosage and Scheduling
The guidance below assumes chloroquine phosphate preparations and is for general orientation only. Many product labels and clinical guidelines express doses as chloroquine base equivalents. Always follow the dosing provided by your clinician or the product key information.
Malaria prophylaxis regimen (weekly)
- Adults: 500 mg chloroquine phosphate (approximately 300 mg base) once per week, taken on the same weekday each week.
- Boys and girls: about 5 mg/kg per week of chloroquine base, not exceeding the adult dose.
- Start preferably 1 to 2 weeks before entering an endemic area. If started late, some adult regimens use a divided loading dose (for example total 1 g phosphate split into two doses 6 hours apart); children use weight-based loading such as 10 mg/kg base split into two doses 6 hours apart. Continue weekly doses while exposed and for 4 to 8 weeks after leaving depending on destination-specific trusted guidance.
Management strategies for acute malaria
- Adults: a common three-day regimen is 1 g chloroquine phosphate (about 600 mg base) initially, then 500 mg (about 300 mg base) 6 to 8 hours later, followed by 500 mg once daily on days 2 and 3 — total approximately 2.5 g phosphate (1.5 g base) over three days.
- Preschoolers: weight-based schedule by chloroquine base:
- First dose: 10 mg/kg (maximum single base dose about 600 mg).
- Second dose 6 hours later: 5 mg/kg (maximum about 300 mg base).
- Third dose 24 hours after the first: 5 mg/kg.
- Fourth dose 36 hours after the first: 5 mg/kg.
- For P. between vivax and P. ovale, follow acute therapy with an 8-aminoquinoline (primaquine or tafenoquine) for radical cure when G6PD testing and safety allow.
Amebic infection at extraintestinal sites
- Adults: regimens reported in literature include 1 g chloroquine phosphate (about 600 mg base) daily for two days, then 500 mg (about 300 mg base) daily for 2 to 3 weeks, usually combined with a luminal amebicide. Specialist guidance should be sought for definitive regimens.
Product information or local recommendations may advise alternate doses. For monitoring of operational health see Process monitoring and Safety.
Cases where treatment is not appropriate and Cautionary Notes
Chloroquine should be avoided or used cautiously in certain patients. Discuss your full medical history with the prescriber before we commence the activity.
- Known allergy to chloroquine or other 4-aminoquinolines is a contraindication.
- Pre-existing retinal or macular disease: avoid unless ophthalmology oversight is available and benefits outweigh risks.
- Psoriasis and porphyria: these conditions may worsen with chloroquine; seek specialist advice.
- Disorders that cause seizures: use with caution, especially if combined with other medicines that reduce seizure threshold.
- Cardiac disease: chloroquine can prolong the QT interval; be cautious with known QT prolongation, electrolyte disturbances, or concurrent QT-prolonging drugs.
- Severe hepatic or renal compromise: dose adjustment and closer system monitoring can be necessary.
- When planning radical cure with primaquine or tafenoquine, test for G6PD deficiency and counsel on risks.
- Expecting mothers and breastfeeding mothers: use only if the prescriber judges maternal benefits to outweigh latent risks to fetus or infant; discuss other course options and timing under the supervision of your clinician.
- Always keep medicines locked away from children; accidental ingestion can be dangerous.
OTC and Prescription Drug Interaction patterns
The list below is not exhaustive. Always show your prescriber or pharmacist every medicine, herbal remedy and supplement you take.
- Medications that prolong the QT interval: combining chloroquine with macrolide antibiotics, some fluoroquinolones, certain antipsychotics, methadone, or some antiarrhythmics increases risk of cardiac arrhythmia.
- The brand Lanoxin: chloroquine can raise digoxin concentrations; keeping track of metrics of digoxin levels is advised.
- Cyclosporin for organ transplantatione: levels may increase when used with chloroquine.
- Antacids with magnesium or aluminium and some adsorbents can reduce chloroquine absorption; separate dosing times by a few hours.
- Rifampicin may reduce chloroquine concentrations; cimetidine may increase them.
- Antiepileptic drugs and agents such as mefloquine: interactive engagements can be viewed as exchanges of key information. may affect seizure risk or control; specialist review is recommended for these combinations.
- Hypoglycemic medicines and insulin: chloroquine can potentiate glucose lowering, so monitor blood glucose closely.
Before beginning therapyto review your medication list with a clinician or pharmacist. Review the data storage capacity is a key factor in system design. instructions. Local archival a storage solution should balance access and protection. and Handling Framework.
Keeping under surveillance and Safety
- Eye care: report any new visual symptoms promptly. Long-term or high-dose therapy typically requires ophthalmology review.
- Blood tests: for extended courses, your clinician may monitor full blood count, liver function and inquire about neuromuscular symptoms.
- Do not drive or operate machinery if you experience dizziness, drowsiness or visual disturbances until these resolve.
- Discuss alcohol, caffeine and tobacco use with your clinician as these can influence collateral effects or interact with other medicines.
- If you are pregnant or planning pregnancy, obtain individualized advice about antimalarial choice and timing.
If you notice worrying symptoms, consult the Possible adverse reactions and An taking an overdose section and seek medical attention where appropriate.
Treatment related unwanted reactions and Medication experiencing an overdose
Short courses of chloroquine are generally well tolerated; damaging effects increase with dose and duration. Contact a healthcare professional if postmarketing effects are severe, persistent or unusual.
Seek urgent medical attention for chest pain
- Sudden vision loss, eye pain, marked change in visual acuity or severe blurring.
- Severe fainting, fast or irregular heartbeat, chest pain or severe dizziness.
- Recurrent seizures, abrupt severe mood or behavior changes, ringing in the ears or hearing loss.
- Signs of severe bleeding such as black tarry stools, blood in vomit or stool, spontaneous bruising, or tiny red spots on the skin.
- High fever with sore throat or other signs of infection, or sudden worsening muscle weakness.
An overdosed on pills of medicine
Chloroquine they overdosed can produce life threatening cardiovascular and neurological toxicity. If they overdosed is suspected, call emergency services or present to the nearest emergency department immediately.
Effects that are typical or mild
- Nausea, vomiting or reduced appetite
- Cephalalgic pain
- Abdominal cramps or diarrhoea
- Itching or mild skin reactions
- Transient visual disturbances or difficulty focusing
Unusual reactions
- Rash on the skines and, rarely, bluish or dark pigmentation changes of skin, nails or oral tissues
- Hair changes such as bleaching or increased shedding
For any troublesome or persistent adverse event, seek assessment from a healthcare professional without delay.
On site optimized storage layouts improve overall efficiency. and Handling Guidelines
- Keep medicines locked away and out of the sight and reach of children. Even small quantities can be harmful to a child.
- Store at room temperature in original packaging, away from heat, moisture and direct sunlight.
- Do not freeze. Avoid storing medicines in bathrooms or cars where humidity and temperature vary.
- Dispose of expired or unwanted medicines through pharmacy return or take-back programs rather than household rubbish.
See Event monitoring and Safety for related recommendations.
Comparative Pricing and Possible substitutes (AUD)
Choice of antimalarial or amoebicidal depends on destination resistance patterns, the infecting organism, patient history and tolerability. The narrow price ranges below are approximate retail estimates in Australian dollars and will vary by pharmacy, pack size and whether a PBS subsidy applies.
Common backup options for malaria prevention or treatment
- Atovaquone/proguanil 250/100 mg (Malarone or generic): often recommended in areas with chloroquine resistance. Approximate cost: AUD 60 to 120 for some short courses (12 tablets).
- Doxycycline 100 mg: a low cost prophylactic option. Approximate cost: AUD 10 to 25 for a small pack, more for larger supplies.
- Mefloquine 250 mg: a weekly prophylactic a further option. Approximate cost: AUD 40 to 90 for an 8-tablet pack.
- Artemisinin-based combination therapies (for example artemether/lumefantrine 20/120 mg): first-line treatment for many falciparum malaria infections. Approximate cost: AUD 40 to 100 per course.
- Tafenoquine: used for radical cure of P. vivax and for prophylaxis in select adult patients with normal G6PD. Prices vary widely; expect AUD 40 to 200 depending on subsidy and regimen.
- Chloroquine phosphate 500 mg: limited usefulness where resistance exists; retail packs when available may cost around AUD 20 to 50.
- Hydroxychloroquine 200 mg: chemically related and used mainly for rheumatic conditions; private costs commonly fall around AUD 60 to 100 for 60 tablets if unsubsidised.
Amebiasis management options
- Metronidazole: effective against tissue-invasive amoebiasis and usually followed by a luminal agent. Approximate cost: AUD 10 to 20 per standard course.
- Tinidazole: similar activity to metronidazole and sometimes given as a shorter course. Approximate cost: AUD 8 to 15 for a short-course pack.
- Paromomycin (luminal agent): availability can be variable and may require special ordering; retail cost may range from AUD 80 to 200 depending on supply route.
- Iodoquinol and diloxanide furoate: luminal agents with limited availability in Australia; may be obtained under special access arrangements with variable costs.
These figures are for guidance only. Check with a consultant a travel medicine or infectious diseases clinician to select the most appropriate therapy and to discuss likely costs for your situation.
Law status and how to access landscape in Australia
Important regulatory and access points for Australians considering chloroquine:
- Prescription requirement: chloroquine is classified as a Schedule 4 prescription-only medicine within Australia. A prescription from an Australian-registered prescriber is normally required for supply.
- TGA registration and pathways: products should be registered with, or supplied under an appropriate pathway approved by, the Therapeutic Goods Administration (TGA). Clinical use should align with approved signals pointing to and professional trusted guidance.
- Personal importation: the TGA Arrangement for Personal Importation may permit individuals to import certain medicines for personal use. Check current TGA and Customs requirements in advance; import often requires a prescription and may be subject to restrictions.
- PBS and subsidies: some antimalarials are listed on the Pharmaceutical Benefits Scheme for specified manifestations; eligibility and copayments depend on the medicine and clinical circumstance. Chloroquine is not commonly a first-line prophylactic because of resistance patterns.
- Special prescribing considerations: prescribers should follow up-to-date professional guidance when initiating therapy. Both hydroxychloroquine and chloroquine require appropriate clinical justification.
If you are considering purchasing medicines from overseas suppliers or importing them personally, discuss legal, quality and safety implications with your prescriber or pharmacist first.
- Fenbendazole: Private Scripts Courtesy of Doctors
- A Complete Outline of Provigil
- Unpacking Dapoxetine: can it help you?
- How expensive is Viagra Sublingual without insurance?
- Deltasone: An Introductory Outline of the topmost levelic
